In April 2015, Georgia launched a program for people infected with the Hepatitis C virus (HCV) and suffering from severe liver disease.

The World Health Organization (WHO) says that Georgia is the third country with the highest rate of patients with hepatitis C, after Egypt and Mongolia.

Many Georgians who suffer from this disease cannot afford the treatment. The American

biopharmaceutical company,

Gilead, is using

Georgia as a test case for Hepatitis C elimination. The free drugs course consists of

Interferon

,

Ribavirin, Sovaldi( Sofosbuvir) and Harvon,

which is the latest medicine, a combination of the drugs

Sofosbuvir and Ledipasvir,

and boasts the highest efficiency

.

Yesterday, Harvon came to Georgia and presented to the public.